Sign inJoin waitlistJoin the waitlist

Joseph Ludwig

Mentor · University of Texas M D Anderson Cancer Center

Credentials: · · ·

History

University of Texas M D Anderson Cancer Center
Present

National Cancer Institute
2002–2006
Mayo Clinic College of Medicine and Science
2001–2002
Internal Medicine
Mayo Clinic College of Medicine and Science
1998–2001
Medical Oncology
1999–2001
University of Iowa Roy J. and Lucille A. Carver College of Medicine
1994–1998

Research

Targeting multidrug resistance in cancer
Review · Nature Reviews Drug Discovery · 2006 · 2,888 citations
Biomarkers in cancer staging, prognosis and treatment selection
Review · Nature reviews. Cancer · 2005 · First of 2 authors · 1,209 citations
Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor
Cancer · 2011 · 190 citations

RB
Robert Benjamin
30 papers
Alexander Lazar
25 papers · 11 as a fellow
Shreyaskumar Patel
24 papers
Neeta Somaiah
19 papers
Dejka Araujo
18 papers
Vinod Ravi
18 papers · 1 as a resident
John Livingston
17 papers · 3 as a fellow
Vivek Subbiah
16 papers · 4 as a fellow
Anthony Conley
14 papers
Najat Daw
14 papers
Ravin Ratan
14 papers · 1 as a fellow
Wei-Lien Wang
14 papers

Grants

RAPID: A Patient-Centric, Investigator-Initiated, Bayesian-Designed, Open-Label, Phase 2 Platform Trial of Promising Drugs for AYA Patients with Relapsed/Refractory Ewing Sarcoma & DSRCT.
Food and Drug Administration · R01
Contact PI · $899.9K · University of Tx Md Anderson Can Ctr
2026–2030
3D Model of Human Ewing Sarcoma
National Cancer Institute · R01
PI · $1.8M · Rice University
2014–2020

Clinical trials

RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT
Principal investigator · Not yet recruiting · Phase 2
M.D. Anderson Cancer Center
2027–2033
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2025–2028